Related Experiment Video
Updated: Jul 18, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[From risk charts to guidelines: tools for evaluation and management of cardiovascular risk]
Cristina Castello1, Furio Colivicchi, Mariagrazia Sclavo
1Cardiologa, AUSL Verona.
Insights
Cardiovascular disease prevention needs precise risk stratification. This review details tools like risk charts and guidelines to bridge the gap between theory and practice for better patient outcomes.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Context:
- Cardiovascular diseases (CVDs) remain a leading cause of mortality despite advancements in diagnostics and therapeutics.
- Rising CVD incidence and lethality pose significant economic burdens on public health systems.
- Current cardiovascular prevention strategies necessitate more precise and effective interventions at both population and individual levels.
Purpose:
- To review and synthesize available tools for global cardiovascular risk stratification.
- To facilitate the clinical implementation of risk assessment instruments, including guidelines for hypertension and dyslipidemias.
- To reduce the discrepancy between theoretical guidelines and real-world clinical application in cardiovascular prevention.
Summary:
- The review focuses on risk stratification tools crucial for effective cardiovascular disease management.
- It examines practical instruments such as risk charts and clinical guidelines for conditions like arterial hypertension and dyslipidemias.
- The objective is to enhance the practical application of these tools by clinicians.
Impact:
- Improved precision in cardiovascular risk assessment can lead to more appropriate and effective therapeutic strategies.
- Facilitating the use of risk stratification tools can optimize resource allocation in public health systems.
- Bridging the gap between guidelines and practice aims to ultimately reduce cardiovascular disease morbidity and mortality.
Abstract:
Despite the wide improvement of diagnostic techniques and the introduction of effective pharmacological and instrumental therapeutic strategies aimed to the treatment of cardiovascular diseases, their incidence and lethality are still elevated, with economic implications increasingly less sustainable by the public medical systems. The modern practice of cardiovascular prevention requires, thus, that diagnostic and therapeutic interventions, both at population level and on the single patient, should be more and more precise, effective, and appropriate. From this point of view, a correct global cardiovascular risk stratification assumes a preponderant relevance, in order to allow an adequate therapeutical response. For this purpose several work instruments, as risk charts and guidelines, namely dedicated to arterial hypertension and dyslipidemias, were developed and offered to clinicians interested in cardiovascular prevention. The aim of this review is to illustrate, in synthesis, those instruments, aiming to facilitate their implementation, thus reducing the actual gap between theoretical indications and the real world.
Related Concept Videos
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Atherosclerosis III: Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Preventive Measures